Navitas Hit with Patent Suit, Stock Slides 9% as Legal Overhang Joins Weak Fundamentals

What happened

Navitas Semiconductor (NVTS) shares fell 9% in pre-market trading on July 8, 2026, after Wolfspeed filed a patent infringement lawsuit covering several core power-chip product lines. This legal overhang arrives as the company already struggles with a deepening revenue decline—Q1 2026 revenue dropped 39% year-over-year to $8.6 million—while operating cash burn remains heavy at $16.4 million per quarter. The DeepValue Master Report rates NVTS a Potential Sell, warning that the stock's premium valuation embeds an AI-rack revenue inflection not yet supported by binding orders or long-term supply agreements. The lawsuit introduces additional uncertainty around Navitas’ intellectual property and could distract management from executing its critical "Navitas 2.0" pivot toward high-power markets. With ~$221 million in cash providing a runway but no clear catalyst for revenue upside, the risk/reward skews increasingly negative as the legal cloud combines with deteriorating fundamentals.

Implication

Investors should treat this lawsuit as a material escalation of risk that validates the Potential Sell thesis. The legal distraction could delay qualification cycles and customer conversions at a time when Navitas needs unimpeded execution to offset mobile/consumer declines. Without confirmed production orders from named AI-rack partners, the current ~$17 stock price is unsupported; the attractive entry target of $12 accounts for the added legal overhang. Position sizing must assume binary legal outcomes that could impair cash and competitive positioning.

Thesis delta

The patent infringement lawsuit from Wolfspeed introduces a new layer of execution risk and potential liability that was not explicitly factored into the base case. While the core investment thesis—that NVTS's valuation relies on unconfirmed AI-rack orders and non-binding announcements—remains intact, the legal overhang increases the probability of a bear-case scenario where revenue recovery is delayed even further. This event does not change the Potential Sell rating but raises conviction in trimming positions above $22 and waiting for a lower entry point under $12 to account for the expanded risk profile.